MOTS-c and Melanotan 2 represent two distinct structural and functional classes of synthetic research peptides utilized across molecular biology and physiology models. While MOTS-c functions as a mitochondrial-derived signaling peptide involved in metabolic homeostasis, Melanotan 2 acts as a non-selective melanocortin receptor agonist. This comparative analysis examines their molecular structures, pharmacokinetics, pathway interactions, and laboratory protocols.
MOTS-c and Melanotan 2 represent two distinct structural and functional classes of synthetic research peptides utilized across molecular biology and physiology models. While MOTS-c functions as a mitochondrial-derived signaling peptide involved in metabolic homeostasis, Melanotan 2 acts as a non-selective melanocortin receptor agonist. This comparative analysis examines their molecular structures, pharmacokinetics, pathway interactions, and laboratory protocols.
MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a 16-amino-acid mitochondrial-derived peptide that primary regulates metabolic homeostasis and cellular stress responses through AMPK activation. In contrast, Melanotan 2 is a synthetic cyclic heptapeptide melanocortin analog researched for melanocortin activity related to skin pigmentation responses and systemic melanocortin receptor signaling. These compounds interact with entirely distinct physiological pathways and serve non-overlapping roles in preclinical research designs.
Investigators selecting between these candidates must evaluate structural composition, receptor affinity, cellular targets, and analytical specifications to align reagent selection with experimental hypotheses. To explore PX1 Research’s complete catalog of analytical-grade compounds, researchers can review our all peptides catalog.
The table below outlines key biochemical and pharmacokinetic criteria for MOTS-c and Melanotan 2 based on published preclinical literature and analytical testing parameters.
| Criteria | MOTS-c | Melanotan 2 | | :--- | :--- | :--- | | **Mechanistic Class** | Mitochondrial-Derived Peptide (MDP) | Synthetic Melanocortin Analog | | **Primary Target / Receptor** | AMPK pathway / Nuclear translocation (AICAR-like) | MC1R, MC3R, MC4R, MC5R Agonist | | **Reported In Vivo Half-Life** | ~4.5 hours (rodent models) | ~1.5–2 hours (terminal plasma) | | **Primary Research Focus** | Metabolic homeostasis, insulin sensitivity, cellular stress | Melanocortin signaling, skin pigmentation responses | | **Solubility Profile** | Water-soluble (PBS, sterile water) | Highly water-soluble (bacteriostatic water, saline) | | **Typical Preclinical Model** | Murine metabolic and endurance models | Rodent melanocortin and pigmentation assays | | **Available Vial Formats** | 10mg lyophilized powder | 10mg lyophilized powder |
For specific purity verifications and batch analysis data, researchers can consult our verified third-party COA repository.
MOTS-c is an endogenous mitochondrial-derived peptide encoded within the mitochondrial 12S ribosomal RNA gene. Composed of 16 amino acids (Met-R-Q-E-M-V-S-W-S-R-N-G-E-K-M-F-NH2), its primary structure allows it to translocate to the nucleus during cellular stress, where it functions as a transcriptional regulator. Because it originates from the mitochondrial genome, MOTS-c represents a novel class of signal transducers that bridge organellar stress to nuclear gene expression.
Melanotan 2 (MT-2) is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH). Chemically designated as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, Melanotan 2 features a cyclic lactam structure between Asp radical and Lys side chains. This structural cyclization provides enhanced metabolic stability and enzymatic resistance compared to endogenous linear melanocortin peptides, allowing for sustained receptor engagement in experimental assays.
Preclinical studies suggest that MOTS-c acts downstream through the activation of 5'-AMP-activated protein kinase (AMPK) without direct binding to classical cell-surface G-protein coupled receptors (GPCRs). In vitro assays indicate that MOTS-c inhibits the folate cycle, leading to the accumulation of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) and subsequent activation of AMPK. This pathway mediates systemic metabolic flexibility, cellular glucose uptake, and mitochondrial biogenesis under metabolic stress conditions. Researchers interested in sourcing high-purity MOTS-c for laboratory research can examine batch-specific analytical documentation.
Conversely, Melanotan 2 functions as a potent, non-selective agonist across multiple melanocortin receptor subtypes, demonstrating high binding affinity for MC1R, MC3R, MC4R, and MC5R. Activation of MC1R on melanocytes stimulates adenylate cyclase, elevating intracellular cyclic AMP (cAMP) levels and upregulating tyrosinase activity. Researched for melanocortin activity related to skin pigmentation responses, Melanotan 2 provides a robust model for investigating GPCR activation, receptor internalization kinetics, and downstream cAMP signaling cascades.
In animal models of high-fat diet-induced metabolic dysfunction, MOTS-c administration demonstrated significant regulation of systemic insulin sensitivity and skeletal muscle glucose uptake. Preclinical literature indicates that MOTS-c translocates to the nucleus in response to metabolic stress, interacting with Nrf2 (nuclear factor erythroid 2-related factor 2) target genes to regulate antioxidant response elements (ARE).
Rodent endurance assays further demonstrate that MOTS-c enhances physical performance and mitochondrial respiration by promoting fatty acid oxidation. These preclinical findings position MOTS-c as a primary candidate for investigations into metabolic flexibility, age-related metabolic decline, and mitochondrial signal transduction.
Melanotan 2 has been extensively evaluated in preclinical models to map the central and peripheral melanocortin pathways. Researched for melanocortin activity related to skin pigmentation responses, MT-2 induces eumelanin synthesis in follicular and cutaneous melanocytes via MC1R activation in rodent models. This mechanism allows investigators to quantify pigmentary transitions and melanogenic gene expression in vitro and in vivo.
Beyond cutaneous pigmentation models, animal studies highlight Melanotan 2's cross-reactivity with central MC3R and MC4R targets within the hypothalamus. Preclinical data indicate that central melanocortin activation by MT-2 influences energy balance, hypophagia, and sympathetic tone. Consequently, MT-2 serves as a reference benchmark for comparative receptor-selectivity studies involving synthetic melanocortin agonists.
The pharmacokinetic profile of MOTS-c in rodent models reveals a rapid distribution phase followed by an elimination half-life of approximately 4.5 hours. Because MOTS-c is susceptible to cleavage by endopeptidases in plasma, long-term cell culture or extended animal assays require calibrated dosing intervals or specialized buffer systems to maintain effective concentrations.
Melanotan 2 exhibits enhanced enzymatic resistance relative to linear peptide hormones due to its cyclic core design. In plasma stability assays, MT-2 demonstrates resistance to rapid aminopeptidase degradation, maintaining a terminal plasma half-life of 1.5 to 2 hours in animal models. Its structural integrity permits stable binding in long-course receptor binding kinetics assays.
Proper reconstitution of lyophilized peptides is essential for maintaining peptide integrity and bioactivity in laboratory assays. Lyophilized MOTS-c and Melanotan 2 vials should be stored at -20°C prior to reconstitution. When preparing solutions for laboratory use, vials should be allowed to equilibrate to room temperature to prevent moisture condensation upon opening.
Reconstitution should be performed using sterile bacteriostatic water or laboratory-grade phosphate-buffered saline (PBS), depending on cell culture toxicity parameters. Reagents should be gently swirled rather than vortexed to prevent shear stress degradation of the peptide chains. To calculate exact molar concentrations and solvent volumes for experimental setups, researchers should utilize our dedicated reconstitution calculator.
Selecting the correct research compound depends entirely on the biological system under evaluation:
• **Select MOTS-c** if your study design investigates mitochondrial signaling, metabolic stress responses, AMPK activation, glucose transporter regulation, or skeletal muscle oxidative capacity. • **Select Melanotan 2** if your study design examines melanocortin receptor activation profiles, cAMP-dependent signaling, dermal melanogenesis, or central melanocortin pathway dynamics.
To review further technical literature, experimental design frameworks, and compound validation protocols, explore our comprehensive research hub.
When evaluating compounds within the melanocortin and cellular regulation space, researchers often compare Melanotan 2 against selective analogs like PT-141 (Bremelanotide), a downstream derivative of MT-2 engineered for greater receptor specificity. In metabolic and mitochondrial research clusters, MOTS-c is frequently studied alongside mitochondrial-targeted compounds such as SS-31 or systemic metabolic regulators like BPC-157. Establishing control groups across these structurally related peptides allows investigators to delineate specific GPCR-mediated actions from generalized cellular stress adaptations.
All research peptides supplied by PX1 Research are synthesized in USA-based, GMP-compliant facilities and undergo stringent quality control protocols. Every product lot undergoes High-Performance Liquid Chromatography (HPLC) to verify structural identity and ensure purity exceeding 99%, coupled with Mass Spectrometry (MS) verification.
Furthermore, our compounds undergo routine endotoxin testing in an ISO 17025 accredited laboratory to guarantee suitability for sensitive cell culture and in vivo preclinical models. PX1 Research offers reliable same-day shipping (Monday–Friday) from our distribution hubs in California and Arizona. Institutional procurement departments and high-volume laboratories can establish specialized accounts through our wholesale catalog.
What is the primary difference in research application between MOTS-c and Melanotan 2?
MOTS-c is a mitochondrial-derived peptide primarily studied for its role in cellular metabolic homeostasis, AMPK activation, and nuclear transcriptional regulation. Melanotan 2 is a synthetic melanocortin analog researched for melanocortin activity related to skin pigmentation responses and GPCR signaling pathways.
How do the half-lives of MOTS-c and Melanotan 2 compare in preclinical models?
In rodent models, MOTS-c exhibits an elimination half-life of approximately 4.5 hours. Melanotan 2 demonstrates a terminal plasma half-life of approximately 1.5 to 2 hours, though its cyclic lactam structure grants higher resistance to enzymatic cleavage compared to linear MSH peptides.
What receptors does Melanotan 2 target in laboratory assays?
Melanotan 2 acts as a non-selective agonist at melanocortin receptors, exhibiting high binding affinity for MC1R, MC3R, MC4R, and MC5R.
What reconstituted solvents are recommended for MOTS-c and MT-2?
Both peptides can be reconstituted using sterile bacteriostatic water for multi-dose laboratory assays or sterile physiological saline/PBS for sensitive in vitro cell culture models where preservative interference must be avoided.
Are MOTS-c and Melanotan 2 approved for human consumption or clinical use?
No. Both MOTS-c and Melanotan 2 are strict research compounds intended exclusively for in vitro and preclinical laboratory research use. They are not intended for human or veterinary administration, medical treatment, diagnosis, or therapy.
How does PX1 Research verify the purity of MOTS-c and Melanotan 2?
Every lot is manufactured in USA-based GMP-compliant facilities and verified by independent ISO 17025 accredited laboratories using HPLC and Mass Spectrometry to ensure peptide purity ≥99% alongside complete endotoxin safety testing.
Where can researchers find batch-specific analytical certificates for these peptides?
Batch-specific Certificates of Analysis (COAs) detailing HPLC chromatograms and mass spectral data are publicly available through the PX1 Research COA portal.
What storage conditions maintain long-term stability of lyophilized peptide vials?
Lyophilized peptide vials should be stored at -20°C in a desiccated environment. Reconstituted peptide solutions should be aliquoted and stored at -80°C to minimize freeze-thaw degradation.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.